The economic costs of rheumatoid arthritis of short evolution;Costes económicos de la artritis reumatoide de corta evolución

Revista Espanola de Reumatologia

Volumn 28, Issue 1, 2001, Pages 4-11

  Vadillo, Jesús Alberto García ^a   Sanz, Santos Castañeda ^a   Prieto, Ángel Luis Carrasco ^b   Carruez, Antonio Jimeno ^c  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b Delegation Territorial del INSALUD en Castilla y León ^*  (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

Economic costs; Rheumatoid arthritis

Indexed keywords

EID: 25744453835     PISSN: 03044815     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Tornero Molina J, Vidal Fuentes J. Impacto social y económico de las enfermedades reumáticas: La discapacidad laboral. Rev Esp Reumatol 1999; 26: 357-66.
2. Felts W, Yelin E. The economic impact of the rheumatic diseases in the United States. J Rheumatol 1989; 16: 867-84.
3. Yelin E, Callahan LF, for the National Arthritis Data Work Group. The economic cost and social and psychological impact of musculoskeletal conditions. Arthritis Rheum 1995; 38: 1351-62.
4. Badley ME. The economic burden of musculoskeletal disorders in Canada is similar to that for cancer, and may be higher. J Rheumatol 1995; 22: 204-6.
5. Markenson JA. Worldwide trends in the socioeconomic impact and long-term prognosis of rheumatoid arthritis. Semin Arthritis Rheum 1991; 21 (Supl 1): 4-12.
6. Jonsson B, Rehnberg C, Borgquist L, Larsson SE. Locomotion status and costs in destructive rheumatoid arthritis. A comprehensive study of 82 patients from a population of 13000. Acta Orthop Scand 1992; 63: 207-12.
7. Prashker MJ, Meenan RF. The total costs of drug therapy for rheumatoid arthritis. A model based on costs of drug, monitoring, and toxicity. Arthritis Rheum 1995; 38: 318-25.
8. Kavanaugh A, Heudebert G, Cush J, Jain R. Cost evaluation of novel therapeutics in rheumatoid arthritis (CENTRA): a decision analysis model. Semin Arthritis Rheum 1996; 25: 297-397.
9. Stone CE. The lifetime economic cost of rheumatoid arthritis. J Rheumatol 1984; 11: 819-27.
10. Rothfuss J, Mau W, Zeidler H, Brenner MH. Socioeconomic evaluation of rheumatoid arthritis and osteoarthritis: A literature review. Semin Arthritis Rheum 1997; 26: 771-9.
11. Tornero Molina J, Atance Martínez JC, Grupeli BE, Vidal Fuentes J. Impacto socioeconómico de la incapacidad temporal de origen reumático en la provincia de Guadalajara. Rev Esp Reumatol 1998; 25: 340-5.
12. Tornero Molina J, Fernández Echevarría JA, Vidal Fuentes J. Repercusión socioeconómica de la invalidez permanente por enfermedad reumática en la provincia de Guadalajara. Rev Esp Reumatol 1998; 25: 346-51.
13. García Vadillo JA. Análisis de la calidad asistencial en el tratamiento de la Artritis Reumatoide. Tesis doctoral. Valladolid. Universidad de Valladolid, 1999.
14. Arnet FC, Edworthy SM, Bloch DA, McShane DJ, Fies JF, Cooper NS et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
15. Guadalajara N. Análisis de costes en los hospitales. Valencia: M/C/Q/ Ediciones, 1994.
16. Lajas C, Sánchez C, Bellajdell B, Abasolo L, Fernández-Gutiérrez B, Morado IC et al. Costes anuales de una cohorte de pacientes diagnosticados de artritis reumatoide (AR) en un hospital de Madrid [resumen]. Rev Esp Reumatol 1991; 26: 157.
17. Lambert CM, Hurst NP, Forbes JF, Lochhead A, Macleod M, Nuki G. Is day care equivalent to inpatient care for active rheumatoid arthritis? Randomised controlled clinical and economic evaluation. Br Med J 1998; 316: 905-9.
18. Mau W, Bornmann M, Weber H. Prediction of permanent work disability in a follow-up study of early rheumatoid arthritis: results of a tree structured analysis using RECPAM. Br J Rheumatol 1996; 35: 652-9.
19. Lambert CM, Hurst NP. Health economics as an aspect of health outcome: Basic principles and application in rheumatoid arthritis. Br J Rheumatol 1995; 34: 774-80.
20. Bedi S, Crook PR, Dick WC, Griffiths ID, Platt P. Cost of providing a rheumatological service. Br J Rheumatol 1987; 26: 454-7.
21. Thould AK. Cost of health care: experience of one department of rheumatology. Br Med J 1985; 291: 957-9.
22. Jacobs J, Keyserling JA, Britton M, Morgan GJ Jr, Wilkenfeld J, Huchings HC. The total cost of care and the use of pharmaceutical in the management of rheumatoid arthritis: the medical program. J Clin Epidemiol 1988; 41: 215-23.
23. Worral P, Chaulk P, Freake D. The effects of clinical practice guidelines on patients outcomes in primary care: A systematic review. Can Med Assoc J 1997; 156: 1705-12.
24. Lambert CM, Hurst NP, Lochhead A, McGregor K, Hunter M, Forbes J. A pilot study of the economic cost and clinical outcome of day patient vs inpatient management of active rheumatoid arthritis. Br J Rheumatol 1994; 33: 383-8.
25. Rao JK, Mihaliak K, Kroenke K, Bradley J, Tierney WM, Weinberger M. Use of complementary therapies for arthritis among patients of rheumatologists. Ann Intern Med 1999; 131: 409-16.
26. Bradley LA, Alberts KR. Psychological and behavioral approaches to pain management for patients with rheumatic disease. Rheum Dis Clin North Am 1999; 25: 215-32.
27. Pennix BW, Beekman AT, Ormel J, Krieegsman DM, Boeke AJ, Van-Eijk JT et al. Psychological status among elderly people with chronic disease: does type of disease play a part? J Psychosom Res 1996; 40: 521-34.
28. Creed F. Psychological disorders in rheumatoid arthritis: a growing consensus. Ann Rheum Dis 1990; 49: 808-12.
29. Rabasa B. Estudio sociológico, libro blanco: la depresión en España. Madrid: Gabinete de Estudios sociológicos Bernard Krief. Lab. Lederle (Cyanamid Ibérica, S.A.) 1983; 4: 30-1.
30. McFarlane AC, Brooks P. An analysis of the relationship between psychological morbidity and disease activity in rheumatoid arthritis. J Rheumatol 1988; 15: 926-31.
31. Blalock SJ, Devellis RF. Rheumatoid arthritis and depression. An overview. Bull Rheum Dis 1992; 41: 6-8.
32. Affleck G, Tennen H, Urrows S. Individual differences in the day-to-day experience of chronic pain: A prospective daily study of rheumatoid arthritis patients. Health Psychol 1991; 10: 419-26.
33. Taal E, Rasker JJ, Timmers C. Measures of physical function and emotional well being for young adults with arthritis. J Rheumatol 1997; 24: 994-7.
34. Raftery J. Economic evaluation: an introduction. Br J Rheumatol 1998; 316: 1013-4.
35. Maetzel A, Bombardier C. Give observational studies a chance: Better observational studies make better economic evaluations. J Rheumatol 1999; 26: 2298-9.
36. Drummond M, O'Brien B, for the Economics Workgroup. Economic analysis alongside clinical trials: Practical considerations. J Rheumatol 1995; 22: 1418-9.